TuesdayMay 30, 2017 10:46 am

ChineseInvestors.com, Inc. (CIIX) Debuts “OptHemp” Premium Line and Readies its First U.S. Retail Store

ChineseInvestors.com’s (OTCQB: CIIX) first retail store is expected to open in June in San Gabriel, California. It will be among the first stores to sell “OptHemp,” a premium health product line launched by CIIX’s wholly owned subsidiary chinesehempoil.com, Inc. The “OptHemp” line will include OptHemp Ultra Premium Hemp Oil, the company’s first private label product. CIIX offers educational tools and consulting services for Chinese investors. Recently, it has been pursuing its niche in the expanding cannabis (CBD) market. The company’s goal is to become a leading Chinese publicly traded company in the nutritional industry. CIIX’s retail store in California will…

Continue Reading

WednesdayMay 24, 2017 9:30 am

QualityStocksNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Announces Launch of ‘OptHemp’ Premium Hemp Health Product Line

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX), through wholly-owned subsidiary Chinesehempoil.com Inc., this morning announced plans to launch its own premium hemp health product line, ‘OptHemp’, as well as its first private label product, OptHemp Ultra Premium Hemp Oil. “We believe that the desire for better quality of life in the Chinese community, coupled with fact that the aging population continues to grow, will lead to continued growth in the alternative health sector and increased demand for natural hemp-based health products,” Warren Wang, founder and CEO of CIIX, stated in the news release. “CIIX is confident that its OptHemp product…

Continue Reading

TuesdayMay 23, 2017 1:02 pm

ChineseInvestors.com (CIIX) Growing Rapidly in a Rapidly Growing Market

Savvy investors study multiple factors to identify potential stock winners. Stock screeners scan thousands of companies for insights and data to discern uncommon opportunities. The criteria utilized in a stock screening system is obviously influenced by an individual’s investment proclivities such as high yield, value, growth or price momentum, however, most stock screening systems are typically hybrids with blended criteria reflecting individual preferences and incorporating more than one investment style. P/E ratios, near zero beta, increased dividends, revenue growth and market growth are all employed to sift through over 100,000 public companies around the world and the nearly 6,000 U.S.…

Continue Reading

MondayMay 15, 2017 9:47 am

ChineseInvestors.com, Inc. (CIIX) Projected To Reach Revenue of $14.8 Million by FY2020 in Consilium Global Research Report

ChineseInvestors.com, Inc. (OTCQB: CIIX) is projected to reach revenues of $14.8 million by fiscal year 2020, according to a new research report by Consilium Global Research (http://dtn.fm/d849H). Per the report, the company did $930,000 in revenue for fiscal 2016 and is projected to grow at a compound annual growth rate (CAGR) of approximately 100% through 2020. The underlying market’s CAGR will expand at an 80% rate, the report said. Consilium sees CIIX as going through a huge transformation this year as it pursues a larger stake in the cannabis market. Headquartered in San Gabriel, California, CIIX offers a range of…

Continue Reading

TuesdayMay 09, 2017 3:19 pm

ChineseInvestors.com, Inc. (CIIX) Aims to Excel in CBD Markets

For nearly two decades, ChineseInvestors.com (OTCQB: CIIX) has delivered a wide range of products, information, and services, including several subscription-based services, for the global Chinese speaking population. The specialized investment services company provides real-time market commentary, analysis, and education-related information in the Chinese language, as well as offering consultation, advertising, and public relations services. The company’s product diversity is a result of its growth-focused, long term quest for value-add opportunities. Not satisfied with a 100,000+ user base, a recognizable 18-year-old brand, and a target market in excess of two billion Chinese speaking people, ChineseInvestors.com recently executed a first-to-market milestone by…

Continue Reading

MondayMay 01, 2017 1:15 pm

ChineseInvestors.com, Inc. (CIIX) Set to Capitalize on Meteoric Growth of CBD Market

The chemical in marijuana that causes euphoria is delta-9 tetrahydrocannabinol, or THC. There are also over 100 other cannabinoid chemicals in the plant, including cannabidiol (CBD), one of the main active chemical compounds found in marijuana. CBD doesn’t make people high, isn’t intoxicating or addictive, and is gaining widespread acceptance as a natural and effective medicinal treatment for multiple disorders. Both anecdotal evidence and pre-clinical research have pointed to CBD as having a broad range of beneficial therapeutic uses, including anti-seizure, antioxidant, neuro-protective, anti-inflammatory, analgesic, anti-tumor, anti-anxiety, and anti-psychotic properties. CBD oil has already been legalized in all 50 U.S.…

Continue Reading

WednesdayApr 26, 2017 3:41 pm

ChineseInvestors.com, Inc. (CIIX) Raises Funds through a Private Placement, Sales of Equities, and Preferred Stock Offerings

ChineseInvestors.com, Inc. (OTCQB: CIIX) is raising funds in a series of offerings, equity sales and a private placement to meet its liquidity needs, even as it reported a 95% gain in its year-over-year operating revenues for the three months ended February 28, 2017. It has begun a private placement of a new series of its preferred stock to its Canadian investors. In 2016, it realized $2.3 million in proceeds from its stock sales of Medicine Man Technologies, Inc. ChineseInvestors.com is a company which, in real-time in the Chinese language, provides analysis and educational services. It also offers consulting and advertising…

Continue Reading

FridayApr 21, 2017 1:20 pm

Epilepsy Patients are the New Focus of ChineseInvestors.com, Inc.’s (CIIX) CBD Health Products

In China, there are close to 10 million epilepsy patients, the Chinese Overseas Medical Advisory Service Center estimates. There is no cure in the country, although risky surgery is sometimes performed in the U.S., where there are over three million people living with epilepsy. Many patients rely on Chinese herbs for temporary control. However, ChineseInvestors.com’s (OTCQB: CIIX) current development plan includes making cannabidiol (CBD) products available online for people with epilepsy and Alzheimer’s disease. Its online store (ChineseCBDoil.com) and Yelp-style mobile application are helping to serve Chinese-speaking consumers around the world, and investors as well, with a reach into the…

Continue Reading

WednesdayApr 12, 2017 2:44 pm

ChineseInvestors.com, Inc. (CIIX) Eyes Germany’s Growing Medical Hemp Market

ChineseInvestors.com, Inc. (OTCQB: CIIX) attended the 'Invest 2017' exhibition in Stuttgart, Germany, on April 7-8, 2017, anticipating that the conference would be an opportunity for CIIX to introduce its hemp companies and products to German investors, but CIIX is not alone in seeing the growth opportunities for medical cannabis in that market. CIIX operates a website for Chinese-speaking investors. It has also opened, in the Shanghai Free Trade Area, a store that distributes CBD health oil products to the global Chinese-speaking population. Germany permits the use of medical marijuana, and it recently further loosened its regulations. Earlier this year, the…

Continue Reading

WednesdayApr 05, 2017 3:29 pm

ChineseInvestors.com, Inc. (CIIX) Combating Alzheimer’s Disease through Development of CBD Health Products

China’s growing economy has proven to be beneficial to many across the country. Some of these benefits include higher living standards, better health and nutrition, and longer life expectancy. Unfortunately, China’s longer-lived population has resulted in a significant increase in the number of people having to care for seniors with various mental dysfunctions, most notably dementia and, in particular, Alzheimer’s disease. Alzheimer’s is a neurodegenerative type of dementia that is most prominent in elderly people. The disease is a disorder that involves the death of brain cells leading to various cases of memory loss and cognitive decline. The disease starts…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered